We are excited to announce a transformative funding milestone that will accelerate our vision at Terrain Bio. In a robust funding round led by Era Finance, we successfully raised $9,400,000—a testament to our innovative approach and commitment to revolutionizing RNA therapeutics manufacturing. At Terrain Bio, we help RNA therapeutics companies design and build better RNA, faster, by leveraging the latest innovations in protein and RNA design along with the deep expertise of our scientific cofounders. With this fresh injection of capital, we are poised to elevate our research and development efforts, enhance our state-of-the-art manufacturing capabilities, and expand our exceptional team of scientists and engineers. This strategic investment will enable us to push the boundaries of RNA production efficiency, quality, and speed, ultimately driving the rapid delivery of breakthrough therapeutics to patients in need. Our renewed focus will be on refining our proprietary processes and scaling our operations to meet the growing demands of the industry, fueling collaboration with promising partners and fueling further innovation across our product pipelines. We view this funding not only as a significant milestone but also as a vote of confidence in our vision and technological expertise. As we embark on this new chapter, our dedicated team is more determined than ever to set new standards in RNA design and manufacturing, paving the way for life-saving treatments and a brighter future in biotech. With Era Finance’s support, Terrain Bio is ready to lead the charge towards more agile, efficient, and groundbreaking RNA therapeutics solutions.
Era Finance Powers RNA Innovation: $9.4M Funding Boost for Terrain Bio's Next-Gen RNA Manufacturing Breakthrough
Get the full Era Finance company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
EarthOptics
EarthOptics is transforming how the world understands and manages soil. By combining next-generation sensors, advanced algorithms, and carbon analytics, we’re building the Soil Cloud—a powerful data platform that empowers farmers to sustainably optimize their operations, increase yields, and feed a growing global population. Our technology delivers high-resolution insights into soil properties at scale, making a positive impact on both environmental health and farm profitability.
$110.0M Series c
today
Otomato.xyz
Meet your Smart DeFi assistant. One setup, zero dashboards. Get hyper-targeted updates on your positions, starting with HyperEVM. ✨
$2.0M Seed
today
Waypoint Bio
Waypoint Bio is a VC-backed biotech startup building the next generation of cell therapies for solid tumors.
$20.0M Series a
today
Crimson
Crimson’s IT recruitment services simplify the recruitment process, helping hiring managers find the best contract and permanent IT talent in established and emerging disciplines. Clients and candidates alike continue to choose Crimson because of three specific reasons: A commitment to keeping promises and delivering first time, supported by a £1M investment in relationship management technology. An unparalleled network and expert market insight from over 20 years’ sector experience. A world-beating level of friendly service borne out by a world-beating Net Promotor Score. Talk to us on 01675 466 477 and discover for yourself why candidates and hiring managers choose Crimson for their IT recruitment solutions.
$2.5M Seed
today
Asteromorph
We are a team of scientists and engineers working on building scientific superintelligence. Our discovery system - an orchestration of AI models designed to drive scientific progress as an independent architect - inspires breakthrough theses and develops them to robust statements with self-conducted experiments in both silicon and physical world.
$31.4M Seed
today